Cyclerion Therapeutics (CYCN) announced that it has entered into a licensing agreement with the Massachusetts Institute of Technology, securing …
Cyclerion Therapeutics (CYCN) announced that it has entered into a licensing agreement with the Massachusetts Institute of Technology, securing the intellectual property that will serve as the cornerstone of its strategic relaunch. This agreement mar… [690 chars]
Source: Markets Insider | Published: 2025-09-23T20:10:24Z
Credit: Markets Insider
